Skip to main content
SpringerLink
Log in

Metformin in women with PCOS, CONS

  • Pros and Cons in Endocrine Practice
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Metformin has a potential role for insulin resistance in polycystic ovary syndrome(PCOS) and has demonstrated efficacy in diabetes. There are a large number of studies and evidence syntheses comparing metformin with control, lifestyle interventions, the oral contraceptive pill, and clomiphene citrate; however, there is still uncertainty about the effectiveness of metformin in women with PCOS. Here we present a systematic overview of the evidence for the use of metformin in women with PCOS. The evidence suggests that metformin continues to have an unclear roll in PCOS until further well designed; methodologically rigorous effectiveness studies with large sample sizes are conducted, and these should include women across the body mass index (BMI) range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25(2), 544–551 (2010). doi:10.1093/humrep/dep399

    Article  PubMed  Google Scholar 

  2. J.A. Boyle, J. Cunningham, K. O’Dea, T. Dunbar, R.J. Norman, Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia. Med. J. Aust. 196(1), 62–66 (2012)

    Article  PubMed  Google Scholar 

  3. S.R. Davis, S. Knight, V. White, C. Claridge, B.J. Davis, R. Bell, Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women. Gynecol. Endocrinol. 16(6), 443–446 (2002)

    Article  CAS  PubMed  Google Scholar 

  4. M. Hickey, D.A. Doherty, H. Atkinson, D.M. Sloboda, S. Franks, R.J. Norman, R. Hart, Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum. Reprod. 26(6), 1469–1477 (2011). doi:10.1093/humrep/der102

    Article  CAS  PubMed  Google Scholar 

  5. NIH Evidence based workshop on Polycystic Ovary Syndrome. http://prevention.nih.gov/workshops/2012/pcos/resources.aspx. (2012)

  6. B.O. Yildiz, G. Bozdag, Z. Yapici, I. Esinler, H. Yarali, Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. (Oxford, England) 27(10), 3067–3073 (2012)

    Article  Google Scholar 

  7. R.J.R.J. Norman, D.D. Dewailly, R.S.R.S. Legro, T.E.T.E. Hickey, Polycystic ovary syndrome. Lancet 370(9588), 685–697 (2007)

    Article  CAS  PubMed  Google Scholar 

  8. H.J. Teede, A.E. Joham, E. Paul, L.J. Moran, D. Loxton, D. Jolley, C. Lombard, Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (2013). doi:10.1002/oby.20213

    Google Scholar 

  9. H.J. Teede, M.L. Misso, A.A. Deeks, L.J. Moran, B.G. Stuckey, J.L. Wong, R.J. Norman, M.F. Costello, Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med. J. Aust. 195(6), S65–S112 (2011)

    Article  PubMed  Google Scholar 

  10. N.K. Stepto, S. Cassar, A.E. Joham, S.K. Hutchison, C.L. Harrison, R.F. Goldstein, H.J. Teede, Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum. Reprod. 28(3), 777–784 (2013)

    Article  CAS  PubMed  Google Scholar 

  11. E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012). doi:10.1210/er.2011-1034

    Article  CAS  PubMed  Google Scholar 

  12. L.J. Moran, M.L. Misso, R.A. Wild, R.J. Norman, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 16(4), 347–363 (2010)

    Article  CAS  PubMed  Google Scholar 

  13. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit, R. Lobo, R.J. Norman, E. Talbott, D.A. Dumesic, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95(5), 2038–2049 (2010). doi:10.1210/jc.2009-2724

    Article  CAS  PubMed  Google Scholar 

  14. L.J. Moran, A.A. Deeks, M.E. Gibson-Helm, H.J. Teede, Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum. Reprod. 27(7), 2082–2088 (2012). doi:10.1093/humrep/des114

    Article  CAS  PubMed  Google Scholar 

  15. A.A. Deeks, M.E. Gibson-Helm, E. Paul, H.J. Teede, Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum. Reprod. 26(6), 1399–1407 (2011)

    Article  CAS  PubMed  Google Scholar 

  16. L.C. Giudice, Endometrium in PCOS: implantation and predisposition to endocrine CA. Best. Pract. Res. Clin. Endocrinol. Metab. 20(2), 235–244 (2006)

    Article  CAS  PubMed  Google Scholar 

  17. B.C.J.M. Fauser, B.C. Tarlatzis, R.W. Rebar, R.S. Legro, A.H. Balen, R. Lobo, E. Carmina, J. Chang, B.O. Yildiz, J.S.E. Laven, J. Boivin, F. Petraglia, C.N. Wijeyeratne, R.J. Norman, A. Dunaif, S. Franks, R.A. Wild, D. Dumesic, K. Barnhart, Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97(1), 28–38 (2012)

    Article  PubMed  Google Scholar 

  18. H.J. Teede, A.E. Joham, E. Paul, L.J. Moran, D. Loxton, D. Jolley, C. Lombard, Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity 21(8), 1526–1532 (2013)

    Article  PubMed  Google Scholar 

  19. R. Pasquali, Metformin in women with PCOS. Pros. Endocrine (2014). doi:10.1007/s12020-014-0311-1

    Google Scholar 

  20. PCOS Australian Alliance: Evidence based guidelines for assessment and management of polycystic ovary syndrome. In: Jean Hailes Foundation for Women’s Health on behalf of the PCOS Australian Alliance Melbourne (2011)

  21. R.S. Legro, S.A. Arslanian, D.A. Ehrmann, K.M. Hoeger, M.H. Murad, R. Pasquali, C.K. Welt, Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98(12), 4565–4592 (2013). doi:10.1210/jc.2013-2350

    Article  CAS  PubMed  Google Scholar 

  22. T. Bridger, S. MacDonald, F. Baltzer, C. Rodd, Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch. Pediatr. Adolesc. Med. 160(3), 241–246 (2006)

    Article  PubMed  Google Scholar 

  23. L. Morin-Papunen, A.S. Rantala, L. Unkila-Kallio, A. Tiitinen, M. Hippelainen, A. Perheentupa, H. Tinkanen, R. Bloigu, K. Puukka, A. Ruokonen, J.S. Tapanainen, Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J. Clin. Endocrinol. Metab. 97(5), 1492–1500 (2012). doi:10.1210/jc.2011-3061

    Article  CAS  PubMed  Google Scholar 

  24. D. Romualdi, M. Giuliani, F. Cristello, A.M. Fulghesu, L. Selvaggi, A. Lanzone, M. Guido, Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Fertil. Steril. 93(7), 2303–2310 (2010). doi:10.1016/j.fertnstert.2009.01.114

    Article  CAS  PubMed  Google Scholar 

  25. M. Costello, B. Shrestha, J. Eden, P. Sjoblom, N. Johnson, Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst. Rev. (1), CD005552 (2007)

  26. Z. Jing, X. Liang-Zhi, W. Tai-Xiang, T. Ying, J. Yu-Jian, The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review. Gynecol. Endocrinol. 24(10), 590–600 (2008). doi:10.1080/09513590802288242

    Article  PubMed  Google Scholar 

  27. C. Meyer, B. McGrath, H. Teede, Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 30, 471–478 (2007)

    Article  CAS  PubMed  Google Scholar 

  28. D.D.G. Curi, A.M. Fonseca, J.A.M. Marcondes, J.A.M. Almeida, V.R. Bagnoli, J.M. Soares Jr, E.C. Baracat, Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol. Endocrinol 28(3), 182–185 (2012). doi:10.3109/09513590.2011.583957

    Article  CAS  PubMed  Google Scholar 

  29. K.A. Martin, R.J. Chang, D.A. Ehrmann, L. Ibanez, R.A. Lobo, R.L. Rosenfield, J. Shapiro, V.M. Montori, B.A. Swiglo, Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(4), 1105–1120 (2008). doi:10.1210/jc.2007-2437

    Article  CAS  PubMed  Google Scholar 

  30. T. Tang, J.M. Lord, R.J. Norman, E. Yasmin, A.H. Balen, Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 5, CD003053 (2012). doi:10.1002/14651858.CD003053.pub5

  31. M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, E. Martinez-Bermejo, M.A. Lasuncion, H.F. Escobar-Morreale, Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92(7), 2453–2461 (2007)

    Article  CAS  PubMed  Google Scholar 

  32. K.M. Hoeger, L. Kochman, N. Wixom, K. Craig, R.K. Miller, D.S. Guzick, A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil. Steril. 82(2), 421–429 (2004)

    Article  CAS  PubMed  Google Scholar 

  33. H.S. Qublan, E.K. Yannakoula, M.A. Al-Qudah, F.I. El-Uri, Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study. Saudi Med. J. 28(11), 1694–1699 (2007)

    PubMed  Google Scholar 

  34. K. Hoeger, K. Davidson, L. Kochman, T. Cherry, L. Kopin, D.S. Guzick, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J. Clin. Endocrinol. Metab. 93(11), 4299–4306 (2008). doi:10.1210/jc.2008-0461

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. P. Popova, E. Ryasantseva, I. Zazerskaya, L. Ivanova, E. Grineva, The role of weight loss and metformin in the improvement of menstrual function in overweight and obese women with polycystic ovary syndrome. Diabetes, Obes. Metab. 12, 87 (2010). doi:10.1111/j.1463-1326.2010.01284.x

    Google Scholar 

  36. R. Pasquali, A. Gambineri, D. Biscotti, V. Vicennati, L. Gagliardi, D. Colitta, S. Fiorini, G.E. Cognigni, M. Filicori, A.M. Morselli-Labate, Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 85(8), 2767–2774 (2000)

    Article  CAS  PubMed  Google Scholar 

  37. X. Sun, D. Zhang, W. Zhang, Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Arch. Gynecol. Obstet. 288(2), 423–430 (2013). doi:10.1007/s00404-013-2756-5

    Article  CAS  PubMed  Google Scholar 

  38. T.I. Siebert, M.I. Viola, D.W. Steyn, T.F. Kruger, Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol. Obstet. Invest. 73(4), 304–313 (2012). doi:10.1159/000335253

    Article  CAS  PubMed  Google Scholar 

  39. J. Xiao, S. Chen, C. Zhang, S. Chang, The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol. Endocrinol. 28(12), 956–960 (2012). doi:10.3109/09513590.2012.705368

    Article  CAS  PubMed  Google Scholar 

  40. T. Moresco, V. Genro, C. Schmitz, C. Souza, J. Cunha-Filho, Metformin alone or combined with clomiphene citrate in women with polycystic ovary syndrome and infertility: systematic review. Fertil. Steril. 96, S129 (2011). doi:10.1016/j.fertnstert.2011.07.504

    Article  Google Scholar 

  41. S. Kar, Clomiphene citrate, metformin or the combination of both, as first line ovulation induction drug in polycystic ovarian syndrome: a randomised controlled trial. Fertil. Steril 1, S359–S360 (2013). doi:10.1016/j.fertnstert.2013.07.849

    Google Scholar 

  42. N. Johnson, Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome–a meta-analysis of randomised trials. Aust. N. Z. J. Obstet. Gynaecol. 51(2), 125–129 (2011). doi:10.1111/j.1479-828X.2010.01274.x

    Article  PubMed  Google Scholar 

  43. S. Palomba, A. Falbo, G.B. La Sala, Clomiphene citrate, metformin or both for ovulation induction in therapy naive women with polycystic ovary syndrome (PCOS)? A descriptive review. Curr. Drug Ther. 8(1), 30–37 (2013). doi:10.2174/1574885511308010004

    Article  CAS  Google Scholar 

  44. R.C. Machado, N.A. Machado, S. Geber, Evaluation of the use of metformin in ovulation result of patients with the polycystic ovary syndrome resistant to isolated use of clomiphene citrate. Jornal Brasileiro de Reproducao Assistida 16(1), 27–31 (2012)

    Google Scholar 

  45. M.L. Misso, M.F. Costello, M. Garrubba, J. Wong, R. Hart, L. Rombauts, A.M. Melder, R.J. Norman, H.J. Teede, Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 19(1), 2–11 (2013). doi:10.1093/humupd/dms036

    Article  CAS  PubMed  Google Scholar 

  46. M.L. Misso, H.J. Teede, R. Hart, J. Wong, L. Rombauts, A.M. Melder, R.J. Norman, M.F. Costello, Status of clomiphene citrate and metformin for infertility in PCOS. Trends. Endocrinol. Metab. 23(10), 533–543 (2012). doi:10.1016/j.tem.2012.07.001

    Article  CAS  PubMed  Google Scholar 

  47. M.S. Alebic, T. Bulum, N. Stojanovic, L. Duvnjak, Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine (2014). doi:10.1007/s12020-014-0182-5

    PubMed  Google Scholar 

  48. R.E. Ratner, C.A. Christophi, B.E. Metzger, D. Dabelea, P.H. Bennett, X. Pi-Sunyer, S. Fowler, S.E. Kahn, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J. Clin. Endocrinol. Metab. 93(12), 4774–4779 (2008). doi:10.1210/jc.2008-0772

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. F. Esfahanian, M.M. Zamani, R. Heshmat, Moini nia, F.: Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome. J Obstet Gynaecol Res 39(4), 806–813 (2013). doi:10.1111/j.1447-0756.2012.02051.x

    Article  PubMed  Google Scholar 

  50. W. Knowler, E. Barrett-Connor, S. Fowler, R. Hamman, J. Lachin, E. Walker, D. Nathan, Diabetes Prevention Program Research Group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)

    Article  CAS  PubMed  Google Scholar 

  51. J.L. Rosenzweig, E. Ferrannini, S.M. Grundy, S.M. Haffner, R.J. Heine, E.S. Horton, R. Kawamori, Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(10), 3671–3689 (2008). doi:10.1210/jc.2008-0222

    Article  CAS  PubMed  Google Scholar 

  52. J.P. Domecq, G. Prutsky, R.J. Mullan, V. Sundaresh, A.T. Wang, P.J. Erwin, C. Welt, D. Ehrmann, V.M. Montori, M.H. Murad, Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 98(12), 4646–4654 (2013). doi:10.1210/jc.2013-2374

    Article  CAS  PubMed  Google Scholar 

  53. H. Teede, A. Deeks, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 (2010). doi:10.1186/1741-7015-8-41

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Monash Centre for Health Research and Implementation, School Public Health and Preventative Medicine, Monash University, MHRP, 43-51 Kanooka Grove, Clayton, VIC, 3168, Australia

    Marie L. Misso & Helena J. Teede

Authors
  1. Marie L. Misso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helena J. Teede
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helena J. Teede.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Misso, M.L., Teede, H.J. Metformin in women with PCOS, CONS. Endocrine 48, 428–433 (2015). https://doi.org/10.1007/s12020-014-0394-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0394-8

Keywords

Search

Navigation